Hematology+Medical oncology Risk assessment and screening note   84148-6

LOINC Code


LOINC code84148-6
nameHematology+Medical oncology Risk assessment and screening note
statusACTIVE

Fully-Specified Name

componentRisk assessment and screening note
propertyFind  =  Finding
timePt  =  Point in time:  To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements.
system{Setting}
scaleDoc  =  Document:  A document that could be in many formats (XML, narrative, etc.)
methodHematology+Medical oncology

Additional Names

short nameHemOnc Risk assess+scrn note

Basic Attributes

classDOC.ONTOLOGY
type2  Clinical
order vs. observationBoth

Associated Observations

LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations.

Member of these Groups

LG38969-8Hematology+Medical oncology|ANYTypeOfService|ANYKindOfNote|ANYSetting
LG38894-8Risk assessment and screening note|ANYRole|ANYSetting
LG41826-5{Setting}|ANYTypeofService|ANYKindofDocument|ANYRole|ANYSubjectMatterDomain

History/Usage

first released
last updated2.58
last change typeADD  - added

Related Names

Asympt
Asymptomatic
Cancer
DOC.ONT
Document
Encounter
Evaluation and management
Evaluation and management note
Finding
Findings
Hematology
Hematology and Oncology
Hematology+Oncology
Heme
HemOnc
notes
Oncology
Point in time
Random
Risk assess and screen
Risk assess+scrn note
Scn
Visit note

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.